Endostatin Levels in Exudative Pleural Effusions

Lung

Volumn 181, Issue 6, 2003, Pages 329-334

  Sumi, M ^a   Kagohashi, K ^a   Satoh, H ^a   Ishikawa, H ^a   Funayama, Y ^a   Sekizawa, K ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Endostatin; Lung cancer; Pleural effusion; Pleuropneumonia; Tuberculosis

Indexed keywords

ENDOSTATIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CYTOLOGY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOLOGY; HUMAN; LUNG CANCER; LUNG TUBERCULOSIS; MALE; PLEURA EFFUSION; PNEUMONIA; PRIORITY JOURNAL;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANGIOGENESIS INHIBITORS; BIOLOGICAL MARKERS; CARCINOMA, LARGE CELL; CARCINOMA, SMALL CELL; CARCINOMA, SQUAMOUS CELL; ENDOSTATINS; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PLEURAL EFFUSION, MALIGNANT; PLEUROPNEUMONIA; TUBERCULOSIS, PLEURAL;

EID: 0348109300     PISSN: 03412040     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00408-003-1035-9     Document Type: Article

References (16)

1. Feldman AL, Tamarkin L, Paciotti GF, Simpson BW, Linehan WM, Yang JC (2000) Serum endostatin levels are elevated and correlate with serum vascular endothelial growth factor levels in patients with stage VI renal cancer. Clin Cancer Res 6:4628-4634
2. Fenton KN, Richardson JD (1995) Diagnosis and management of malignant pleural effusions. Am J Surg 170:69-74
3. Garcia-Pachon E, Llorca I (2002) Diagnostic value of C-reactive protein in exudative pleural effusions. Eur J Intern Med 13:246-249
4. Hebbar M, Peyrat J, Hornez L, Hatron P, Hachulla E, Devulder B (2000) Increased concentrations of the circulating angiogenesis inhibitor endostatin in patients with systemic sclerosis. Arthritis Rhem 43:889-893
5. Helfer L, Tempfer C, Kainz C, Obermair A (1999) Serum concentrations of endostatin in patients with vulvar cancer. Gynecol Oncol 74:151-152
6. Homer JJ, Greenman J, Stafford ND (2002) Circulating angiogenic cytokines as tumor markers and prognostic factors in head and neck squamous cell carcinoma. Clin Otolaryngol 27:32-37
7. Miyashita M, Tajiri T, Yanagi K, Shimizu T, Futami R, Sasajima K, Tokunaga A (2003) Serum levels of vascular endothelial growth factor, basic fibroblast growth factor and endostatin in human metastatic liver tumors. Hepatogastroenterology 50:308-309
8. Naito T, Satoh H, Ishikawa H, Yamashita YT, Kamma H, Takahashi H, Hasegawa S (1997) Pleural effusion as a significant prognostic factor in non-small cell lung cancer. Anticancer Res 17:4743-4746
9. Qin LX, Tang ZY (2002) The prognostic molecular markers in hepatocellular carcinoma. World J Gastroenterol 8:385-392
10. Satoh H, Sumi M, Yagyu H, Ishikawa H, Suyama T, Naitoh T, Saitoh T, Hasegawa S (1995) Clinical evaluation of CYFRA 21-1 in malignant pleural fluids. Oncology 53:211-214
11. Shaarawy M, El-Sharkawy SA (2001) Biomarkers of intrinsic angiogenic and anti-angiogenic activity in patients with endometrial hyperplasia and endometrial cancer. Acta Oncol 40:513-518
12. Suzuki M, Iizasa T, Ko E, Baba M, Saitoh Y, Shibuya K (2002) Serum endostatin correlates with progression and prognosis of non-small cell lung cancer. Lung Cancer 35:29-34
13. Tamura S, Nishigaki T, Moriwaki Y, Fujioka H, Nakano T, Fujii J, Yamamoto T, Nabeshima K, Hada T, Higashino K (1988) Tumor markers in pleural effusion diagnosis. Cancer 61:298-302
14. van Hensbergen Y, Broxterman HJ, Hanemaaijer R, Jorna AS, van Lent NA, Verheul HMW, Pinedo HM, Hoekman K (2002) Soluble aminopeptidase N/CD 13 in malignant and nonmalignant effusions and intratumoral fluid. Clin Cancer Res 8:3747-3754
15. Wu P, Yonekura H, Li H, Nosaki I, Tomono Y, Naito I, Nimomiya Y, Yamamoto H (2001) Hypoxia down-regulates endostatin production by human microvascular endothelial cells and pericytes. Biochem Biophys Res Commun 288:1149-1154
16. Yamagata M, Shiratori Y, Dan Y, Shiina S, Takayama T, Makuuchi M, Omata M (2000) Serum endostatin levels in patients with hepatocellular carcinoma. Ann Oncol 11:761-762